Drug
Ketorolac
Ketorolac: highest development phase Phase 2, developed by Assertio Holdings. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Assertio Holdings
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ketorolac NCT06083571 | Phase 2 | Headache, Migraine |
Latest
No recent events.
Follow Ketorolac on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.